6.750GBp0.00%Mkt Cap: 14.72M GBpP/E: —Last update: 2026-05-13
IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collectio…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-7.67
PEG—
P/B0.53
P/S2.25
EV/EBITDA-1.21
EV/Revenue0.44
EPS (TTM)-0.02
EPS (Forward)-0.01
Cash Flow & Leverage
FCF Yield-9.05%
FCF Margin-20.39%
Operating CF-1.01M GBp
CapEx (TTM)870.00K GBp
Net Debt/EBITDA1.40
Net Debt-3.36M GBp
Technical
SMA 507.369 (-8.4%)
SMA 20010.25 (-34.2%)
Beta0.07
S&P 52W Chg24.23%
Avg Vol (30d)140.43K
Avg Vol (10d)80.00K
Technical Indicators
RSI (14)21.4
MACD-0.2415
MACD Signal-0.2528
MACD Hist.+0.0113
BB Upper7.384 GBp
BB Middle6.987 GBp
BB Lower6.591 GBp
BB Width11.35%
ATR (14)0.3178 GBp
Vol Ratio (20d)0.05x
52W Range
6.2606% of range15.00
52W High15.00 GBp
52W Low6.260 GBp
Profitability
Gross Margin48.71%
EBITDA Margin-36.76%
Profit Margin-25.27%
Oper. Margin-48.86%
ROE-14.07%
ROA-11.93%
Revenue Growth3.00%
Earnings Growth—
Balance Sheet
Debt/Equity0.02
Current Ratio3.03
Quick Ratio2.85
Book Value/Sh0.1270 GBp
Cash/Share0.0380 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateSep 4, 2013
Ownership
Shares Out.218.05M
Float41.02M
Insiders4.89%
Institutions82.94%
Analyst Consensus
Rating—
Target (Mean)26.00 GBp
Target Range26.00 GBp – 26.00 GBp
# Analysts1
Company
Market Cap14.72M GBp
Enterprise Value2.90M GBp
Revenue (TTM)6.53M GBp
Gross Profit3.18M GBp
Net Income (TTM)-1.65M GBp
Revenue/Share0.0730 GBp
Fiscal Year EndSep 2025
MR QuarterSep 2025
Employees79
Last Price6.750 GBp
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—